These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31711134)

  • 1. The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.
    Kent DM; Paulus JK; van Klaveren D; D'Agostino R; Goodman S; Hayward R; Ioannidis JPA; Patrick-Lake B; Morton S; Pencina M; Raman G; Ross JS; Selker HP; Varadhan R; Vickers A; Wong JB; Steyerberg EW
    Ann Intern Med; 2020 Jan; 172(1):35-45. PubMed ID: 31711134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.
    Kent DM; van Klaveren D; Paulus JK; D'Agostino R; Goodman S; Hayward R; Ioannidis JPA; Patrick-Lake B; Morton S; Pencina M; Raman G; Ross JS; Selker HP; Varadhan R; Vickers A; Wong JB; Steyerberg EW
    Ann Intern Med; 2020 Jan; 172(1):W1-W25. PubMed ID: 31711094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the PATH Statement on Analysis and Reporting of Heterogeneity of Treatment Effect in Clinical Trials: A Scoping Review.
    Selby JV; Maas CCHM; Fireman BH; Kent DM
    medRxiv; 2024 May; ():. PubMed ID: 38766150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome risk model development for heterogeneity of treatment effect analyses: a comparison of non-parametric machine learning methods and semi-parametric statistical methods.
    Xu E; Vanghelof J; Wang Y; Patel A; Furst J; Raicu DS; Neumann JT; Wolfe R; Gao CX; McNeil JJ; Shah RC; Tchoua R
    BMC Med Res Methodol; 2024 Jul; 24(1):158. PubMed ID: 39044195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dealing with heterogeneity of treatment effects: is the literature up to the challenge?
    Gabler NB; Duan N; Liao D; Elmore JG; Ganiats TG; Kravitz RL
    Trials; 2009 Jun; 10():43. PubMed ID: 19545379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: A secondary analysis of three randomised controlled trials.
    Sinha P; Spicer A; Delucchi KL; McAuley DF; Calfee CS; Churpek MM
    EBioMedicine; 2021 Dec; 74():103697. PubMed ID: 34861492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
    Santhakumaran S; Gordon A; Prevost AT; O'Kane C; McAuley DF; Shankar-Hari M
    Crit Care; 2019 May; 23(1):156. PubMed ID: 31053084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer.
    Willke RJ; Zheng Z; Subedi P; Althin R; Mullins CD
    BMC Med Res Methodol; 2012 Dec; 12():185. PubMed ID: 23234603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    Goligher EC; Lawler PR; Jensen TP; Talisa V; Berry LR; Lorenzi E; McVerry BJ; Chang CH; Leifer E; Bradbury C; Berger J; Hunt BJ; Castellucci LA; Kornblith LZ; Gordon AC; McArthur C; Webb S; Hochman J; Neal MD; Zarychanski R; Berry S; Angus DC;
    JAMA; 2023 Apr; 329(13):1066-1077. PubMed ID: 36942550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing heterogeneity of treatment effect in multiple sclerosis trials.
    Sormani MP; Chataway J; Kent DM; Marrie RA
    Mult Scler; 2023 Aug; 29(9):1158-1161. PubMed ID: 37555493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Heterogeneity of Treatment Effects: Are Authors Misinterpreting Their Results?
    Fernandez Y Garcia E; Nguyen H; Duan N; Gabler NB; Kravitz RL
    Health Serv Res; 2010 Feb; 45(1):283-301. PubMed ID: 19929962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.
    Kent DM; Steyerberg E; van Klaveren D
    BMJ; 2018 Dec; 363():k4245. PubMed ID: 30530757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials.
    Rigdon J; Baiocchi M; Basu S
    Trials; 2018 Jul; 19(1):382. PubMed ID: 30012181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall average treatment effects from clinical trials, one-variable-at-a-time subgroup analyses and predictive approaches to heterogeneous treatment effects: Toward a more patient-centered evidence-based medicine.
    Kent DM
    Clin Trials; 2023 Aug; 20(4):328-337. PubMed ID: 37148125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.
    Kent DM; Rothwell PM; Ioannidis JP; Altman DG; Hayward RA
    Trials; 2010 Aug; 11():85. PubMed ID: 20704705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring heterogeneity of treatment effect in patients with sepsis: Protocol for a scoping review.
    Søndergaard L; Andreasen AS; Perner A; Niemann C
    Acta Anaesthesiol Scand; 2024 Nov; 68(10):1544-1548. PubMed ID: 38973287
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.